Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis

被引：0

作者：

Silverberg, Jonathan, I ^{[1
]}

Bieber, Thomas ^{[2
,3
]}

Paller, Amy ^{[4
]}

Beck, Lisa A. ^{[5
]}

Kamata, Masahiro ^{[6
]}

Puig, Luis ^{[7
]}

Wiseman, Marni ^{[8
,9
]}

Ezzedine, Khaled ^{[10
]}

Foley, Peter ^{[11
]}

Johansson, Erin ^{[12
]}

Dossenbach, Martin ^{[12
]}

Akmaz, Bulent ^{[13
]}

Casillas, Marta ^{[12
]}

Karlsson, Andrei ^{[14
]}

Chovatiya, Raj ^{[15
]}

机构：

[1] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA

[2] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany

[3] Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland

[4] Northwestern Univ, Dept Dermatol, Chicago, IL USA

[5] Univ Rochester, Med Ctr, Rochester, NY USA

[6] Teikyo Univ, Sch Med, Dept Dermatol, Tokyo, Japan

[7] Hosp Santa Creu & Sant Pau, Dept Dermatol, Barcelona, Spain

[8] Univ Manitoba, Sect Dermatol, Winnipeg, MB, Canada

[9] SKiNWISE Dermatol, Winnipeg, MB, Canada

[10] Univ Paris Est, EpiDermE, Paris, France

[11] Skin Hlth Inst, Melbourne, Vic, Australia

[12] Eli Lilly & Co, Indianapolis, IN USA

[13] Almirall SA, Barcelona, Spain

[14] Costello Med, London, England

[15] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷

关键词：

atopic dermatitis; lebrikizumab; network meta-analysis; targeted systemic therapy;

D O I：

10.1093/bjd/ljae266.014

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

630

引用

页码：15 / 16

页数：2

共 50 条

[31] Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis
Ou, Zuzhen
Chen, Chao
Chen, Aijun
Yang, Yao
Zhou, Weikang
INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 54 : 303 - 310
[32] Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Wang, Fa-Ping
Tang, Xiao-Ju
Wei, Chuan-Qi
Xu, Lin-Rui
Mao, Hui
Luo, Feng-Ming
JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 90 (02) : 190 - 198
[33] Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis
Devjani, Shivali
Engel, Priya, V
Javadi, Sogol S.
Smith, Brandon
Wu, Jashin J.
LANCET, 2023, 402 (10415): : 1833 - 1834
[34] Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
Meher, Bikash Ranjan
Mohanty, Rashmi Ranjan
Padhy, Biswa Mohan
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2335 - 2343
[35] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
Zeng, Linxi
Feng, Sen
Yao, Lulu
Wang, Bin
Zhang, Guoqiang
POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 734 - 740
[36] Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized controlled trials
Wu, Shuying
Wang, Huiping
POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (03): : 601 - 610
[37] Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
Paller, Amy
Flohr, Carsten
Eichenfield, Lawrence F.
Irvine, Alan D.
Pinto-Correia, Ana
Natalie, Chitra R.
Pierce, Evangeline
Reifeis, Sarah
Lima, Renata Gontijo
Laquer, Vivian
Weidinger, Stephan
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 60 - 61
[38] Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
Paller, Amy
Flohr, Carsten
Eichenfield, Lawrence F.
Irvine, Alan
Pinto-Correia, Ana
Natalie, Chitra R.
Pierce, Evangeline
Reifeis, Sarah
Lima, Renata Gontijo
Laquer, Vivian
Weidinger, Stephan
Isho, Nadine
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[39] Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
Paller, Amy
Flohr, Carsten
Eichenfield, Lawrence F.
Irvine, Alan
Correia, Ana Pinto
Natalie, Chitra R.
Pierce, Evangeline
Lima, Renata Gontijo
Laquer, Vivian
Weidinger, Stephan
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB84 - AB84
[40] Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
Roekevisch, Evelien
Spuls, Phyllis Ira
Kuester, Denise
Limpens, Jacqueline
Schmitt, Jochen
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : 429 - 438

← 1 2 3 4 5 →